Study on the Interaction of Algal Peptides on Virulence Factors of Helicobacter pylori: In Silico Approach
Davoodbasha MubarakAli1, Thirusangu Akshaya2, Raghunathan Sathya2
1School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, Tamil Nadu, India. mubinano@gmail.com.
Abstract:
In the Asian region, Helicobacter pylori infects about 80% populations, which is most leading cause of peptic ulcers, and it is an asymptomatic infection. Studies reported that the particular bacteria carry specific virulence factors that leads to severe complications. These virulence factors can be used as a drug targets to inhibit their growth and pathogenicity. Chronic infection with H. pylori virulence factors are CagA, VacA and HtrA positive strains the risk factor of gastric cancer. In this study, we aimed to study the antagonistic interaction pattern between the potential eight algal peptides against the virulence factors of H. pylori through in silico analysis intended to treat peptic ulcer and prevent the further complications such as cancer. The proteins of virulent factors are docked using C-Docker algorithm and calculated the bind energy of the complexes. The results showed that the peptide derived from a green alga, Tetradesmus sp. are active against the three virulent factors such as cag-A, vac-A, and Htr-A with multiple hydrogen, vdW, electrostatic interactions, and mild π-hydrophobic bindings with the libdock energy score for CagA, VacA and HtrA are 175.625, 158.603 and 89.397 kcal/mol. These primes and the peptide lead to develop a better and potential inhibitors against H. pylori infection.
Insights
Green algae peptides show promise in inhibiting Helicobacter pylori virulence factors, offering a potential new treatment for peptic ulcers and a preventative measure against gastric cancer. This discovery could lead to novel drug development.
Area of Science:
- Biotechnology
- Marine Biology
- Computational Biology
Background:
- Helicobacter pylori infection is highly prevalent in Asia, causing peptic ulcers and increasing gastric cancer risk.
- Virulence factors like CagA, VacA, and HtrA in H. pylori strains are key contributors to severe complications.
- Targeting these virulence factors presents a therapeutic strategy to combat H. pylori infections.
Purpose of the Study:
- To investigate the antagonistic interactions between algal peptides and H. pylori virulence factors.
- To identify potential peptide-based inhibitors for H. pylori through in silico analysis.
- To explore novel treatments for peptic ulcers and gastric cancer prevention.
Main Methods:
- In silico analysis was employed to study interactions between eight algal peptides and H. pylori virulence factors.
- Molecular docking using the C-Docker algorithm was performed to assess binding affinities.
- Binding energies of peptide-virulence factor complexes were calculated.
Main Results:
- A peptide from the green alga Tetradesmus sp. demonstrated significant activity against CagA, VacA, and HtrA.
- Effective interactions included hydrogen bonds, van der Waals, and electrostatic forces, with mild π-hydrophobic bindings.
- Libdock energy scores for CagA, VacA, and HtrA complexes were 175.625, 158.603, and 89.397 kcal/mol, respectively.
Conclusions:
- Algal peptides, particularly from Tetradesmus sp., show potential as effective inhibitors of H. pylori virulence factors.
- These findings suggest a promising avenue for developing new therapeutic agents against H. pylori infections.
- This research paves the way for novel treatments targeting peptic ulcers and preventing H. pylori-associated gastric cancer.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...


